HOME > 教室について > 業績リスト > 【学会発表】国際学会 > 2010年
2010年
The 59th Annual Scientific Session of the American College of Cardiology, and i2 Summit with i-Science, 3.14-16, Atlanta, USA
1) Tamura T, Kimura T, Mitsudo K, Morimoto T, Kadota K, Hayashi Y, Nobuyoshi M, on behalf of the j-Cypher Registry investigators: Three-year Clinical and Angiographic Outcomes after implantation of Sirolimus-Eluting Stent with T-stenting Technique in Coronary Bifurcation Lesions from j-Cypher Registry.
2) Ozasa N, Morimoto T, Hou H, Tamura T, Shizuta S, Mitsudo K, Kimura T, on behalf of J-cypher Registry: Does Oral Beta-Blocker Therapy Improve Long-term Clinical Outcomes of ST-elevation Acute Myocardial Infarction after Primary Angioplasty?
3) Imai M, Kadota K, Otsuru S, Okamoto Y, Tasaka H, Hasegawa D, Habara S, Tanaka H, Maruo T, Hirono A, Hosogi S, Fuku Y, Oka N, Katoh H, Yamamoto H, Fujii S, Goto T, Inoue K, Mitsudo K: Prevalence and Clinical Impact of Coronary Artery Aneurysm after Sirolimus-eluting Stent Implantation: Long-term Clinical and Angiographyc Follow-up.
4) Tada T, Tamura T, Tazaki J, Jinnai T, Ozasa N, Shizuta S, Ono K, Horiuchi H, Kimura T: Improvement of Severe Anemia in Patients with Aortic Stenosis Complicated with Gastrointestinal Bleeding from Angiodysplasia (Heyde's syndrome) after Aortic Valve Repair.
5) Tada T, Kimura T, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Nakashima H, Namura M, Inoue N, Nishikawa H, Nakao K, Mitsudo K for the j-Cypher Registry Investigators: Comparison of Three-Year Clinical Outcomes after Sirolimus-eluting Stent Implantation among Insulin-treated Diabetic, Non-insulin-treated Diabetic and Non-diabetic Patients: an Observation from the j-Cypher Registry.
6) Shiomi H, Tamura T, Katoh Y, Tada T, Tazaki J, Jinnai T, Ono K, Kimura T: Long-term Clinical Outcomes of Unprotected Left-main Stenting with Sirolimus Eluting Stents: Correlation between the SYNTAX Score and Clinical Outcomes.
7) Hayano M, Shizuta S, Nakao T, Doi T, Kimura T, Andou K, Arita T, Nobuyoshi M, Fujii S, Inoue K, Isshiki T: Cardiac Resynchronization Therapy for Patients with Heart Failure and Chronic Atrial Fibrillation.
8) Nakao T, Kimura T, Morimoto T, Shizuta S, Tamura T, Doi T, Mitsudo K, on behalf of the j-Cypher Registry Investigators: The Efficacy And Safety of Triple Antiplatelet Therapy After Percutaneous Coronary Intervention (PCI) in j-Cypher Registry.
9) Miyamoto S, Inoko M, Haruna T, Oba M, Saji Y, Nakane E, Abe T, Sasaki K, Itoh H, Fukuda T, Nakashima J, Tanaka N, Ueyama K, Nohara R, Fujita M: Treatment with whole body periodic acceleration with a horizontal motion platform reverses left ventricular remodeling in patients with old myocardial infarction.
10) Fukuda S, Shimada K, Kawasaki T, Kono Y, Jisso S, Taguchi H, Maeda K, Yoshiyama M, Fujita M, Yoshikawa J: Whole body periodic acceleration improves coronary microcirculation in healthy subjects and patients with coronary artery disease.
TCT ASIA 2010, 4.29, Seoul, Korea
1) Tazaki J, Tamura T, Ono K, Abe M, Suyama T, Kimura T: One-Year Cardiovascular and Renal Outcome of Sodium Bicarbonate in Comparison with Saline for Prevention of Contrast-Induced Nephropathy after Cardiac Catheterization Angioplasty.
2) Tazaki J, Kimura T: The Tough Management of Bifurcated and Severe Calcified Lesion.
3) Katoh Y, Tamura T, Kimura T: Left Main Stenting: No More Routine Surgery.
TCTAP 2010, 4.28-30, Seoul, Korea
Nakao T, Tamura T, Kimura T, Miwa S, Yamazaki K, Sakata R: A Case of Left Ventricular Free Wall Rupture Due to Obstruction of Diagonal Branch Complicated by Percutaneous Coronary Intervention for Left Anterior Descending Artery.
ESC 2010, 8.28, Stockholm, Sweden
1) Imai M, Kimura T, Kadota K, Otsuru S, Okamoto Y, Tasaka H, Hasegawa D, Habara S, Tanaka H, Maruo T, Hirono A, Hosogi S, Fuku Y, Oka N, Katoh H, Yamamoto H, Fujii S, Goto T, Inoue K, Mitsudo K: The Comparison of Coronary Artery Aneurysms After Stent Implantation between Bare Metal Stent and Drug-Eluting Stent: Long-term Clinical and Angiographic Follow-up.
2) Watanabe S, Ono K, Horie T, Nishi H, Kuwabara Y, Kimura T: Ca2+/calmodulin-dependent kinase kinase beta contributes to energy supply in adaptive phase of pressure-overload-induced heart failure.
American Heart Association Scientific Sessions 2010, 11.13-17, Chicago, U.S.A.
1) Tazaki J, Horiuchi H, Jinnai T, Tada T, Ikeda T, Yamane K, Kimura T: 13C Pantoprazole Breath Test can Predict the Antiplatelet Effect of Clopidogrel Rapidly.
2) Kobayashi N, Kume N, Hata N, Seino Y, Yokoyama S, Inami T, Yamamoto M, Shinada T, Tomita K, Kitamura M, Mizuno K: Time-dependent changes in matrix metalloproteinase-9 at the earliest stage of ST elevation acute coronary syndrome: Comparison with other biomarkers.
3) Kawashima T, Inuzuka Y, Okuda J, Kato T, Niizuma S, Tamaki Y, Narazaki M, Matsuda T, Adachi S, Takemura G, Kita T, Kimura T, Shioi T: Constitutive SIRT1 overexpression impairs mitochondrial function in mice.
4) Niizuma S, Inuzuka Y, Okuda J, Kawashima T, Kato T, Tamaki Y, Kawamoto A, Iwanaga Y, Yoshida Y, Kosugi R, Watanabe-maeda K, Machida Y, Tsuji S, Aburatani H, Izumi T, Kita T, Kimura T, Shioi T: A constitutive activation of phosphoinositide 3-kinase modifies cardiac aging in mice.
5) Okuda J, Niizuma S, Kato T, Inuzuka Y, Kawashima T, Tamaki Y, Iwanaga Y, Kita T, Kimura T, Shioi T: Overexpression of phosphoglycerate mutase, a glycolytic enzyme, induces proinflammatory response and impairs cardiac function.
6) Tamaki Y, Iwanaga Y, Okuda J, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Shioi T, Ono K, Koshimizu T, Miyazaki S, Kita T, Kimura T: Metastasis-associated protein S100A4 contributes to cardiac fibrosis through the modulation of PTEN.
7) Ono K, Sowa N, Horie T, Hasegawa K, Kita T, Kimura T: MicroRNA 26b family encoded by the introns of small CTD Phosphatases (SCPs) 1 to 3 suppresses phenylephrine-induced cardiomyocyte hypertrophy by targeting TRPC3/6 and GATA4
8) Horie T, Ono K, Iwanaga Y, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E, Hasegawa K, Kita T, Kimura T: MiR-146a-induced inhibition of the neuregulin-ErbB4 pathway may be involved in deterioration of cardiotoxicity under concurrent chemotherapy with doxorubicin and Trastuzumab.
9) Watanabe S, Ono K, Horie T, Nishi H, Kinoshita M, Kuwabara Y, Baba O, Kimura T: Ca2+/Calumodulin-dependent kinase kinase beta contributes to energy supply in adaptive phase of pressure-overload-induced heart failure.
10) Nishi H, Ono K, Horie T, Nagao K, Kinoshita M, Kuwabara Y, Baba O, Nakashima Y, Nagao K, Takanabe-Mori R, Hasegawa K, Kita T, Kimura T: MicroRNA-27a regulates beta-myocin heavy chain gene expression by targeting thyroid hormone receptor beta 1 in neonatal rat ventricular myocytes.
11) Kuwabara Y, Ono K, Horie T, Nishi H, Kinoshita M, Watanabe S, Nakashima Y, Nagao K, Kojima Y, Kita T, Kimura T: MicroRNA-1 and microRNA-133a are useful as early diagnostic biomarkers in patients with acute coronary syndrome.
12) Wada H, Akao M, Masunaga N, Takaya T, Takanabe-Mori R, Abe M, Funatsu J, Nakajima Y, Kanasaki M, Osakabe G, Nakano T, Ono K, Satoh-Asahara N, Shimatsu A, Hasegawa K: Serum adiponectin levels are increased by pathophysiologically induced left ventricular hypertrophy.
13) Takanabe-Mori R, Ono K, Sowa N, Wada H, Takaya T, Satoh-Asahara N, Shimatsu A, Fujita M, Sawamura T, Hasegawa K: Lox-1 is required for the adiposal expression of proinflammatory cytokines in high-fat diet-induced obese mice.
14) Tamaki Y, Okuda J, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Shioi T, Ono K, Koshimizu T, Miyazaki S, Kita T, Kimura T: Metastasis-associated protein S100A4 contributes to cardiac fibrosis through the modulation of PTEN.
15) Kishimoto C, Okabe T, Zuyi Yuan, Shioji K: Immunoglobulin treatment suppresses free radical-mediated myocardial injury in experimental autoimmune myocarditis.
16) Kishimoto C, Shimada K, Hirano E, Komiyama T, Mikami Y, Fujita M: Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, accelerates healing process via nitric oxide in experimental autoimmune myocarditis in rats.
17) Matsuoka T, Hiraoka Y, Ohno M, Nishi K, Kimura T, Kita T, Nishi E: A Metalloendopeptidase Nardilysin controls Lipid and Glucose metabolism through the modulation of Peroxisome Proliferator-activated Receptor alpha activity.
18) Yamanaka K, Ikarashi J, Kusuhara T, Ann K, Nakatsuka D, Hirose K, Iwakura A, Fujita M: A new MAZE procedure with intensive pulmonary veins isolation.
19) Takanabe-Mori R, Ono K, Sowa N, Wada H, Takaya T, Satoh-Asahara N, Shimatsu A, Fujita M, Sawamura T, Hasegawa K: LOX-1 is required for the adiposal expression of proinflammatory cytokines in high-fat diet-induced obese mice.
3rd Asian Preventive Cardiology & Cardiac Rehabilitation Conference, 12.11, Hong Kong, China
Ozasa N, Morimoto T, Bao B, Shioi T, Kimura T: Effect of Passive Cycling on Systemic Endothelial Function in Elderly Patients with Heart Failure: A Pilot Report.
20th International Kitano Endocrinology Seminar, 5.6, Osaka, Japan
Kume N: Soluble lectin-like oxidized LDL receptor-1 is a diagnostic and prognostic biomarker for acute coronary syndrome.
XX World Congress ISHR 2010 Kyoto, 5 13-16, Kyoto, Japan
1) Kawashima T, Shioi T, Inuzuka Y, Okuda J, Kato T, Niizuma S, Tamaki Y, Iwanaga Y, Narazaki M, Matsuda T, Kita T, Kimura T: SIRT1 overexpression caused metabolic remodeling of heart.
2) Ono K, Nishi H, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, Takanabe-Mori R, Hasegawa K, Kita T, Kimura T: MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes.
The International Symposium on Aging and Anti-aging, from Molecular Biology to Nutritional Science, 9.24, Tokyo, Japan
Shioi T: Analysis of aging at organ level, heart as a model system.
Heart Rhythm 2010, 5.12-15, Denver, USA
Makiyama T, Ohno S, Wu J, Kimura T, Horie M: (Joint session. Revision of Clinical Practice for Atrial and Ventricular Arrhythmias in Asia-Pacific Region.) Inherited Ventricular Arrhythmic Disorders in Asia: What’s New and What’s Different from US and Europe? (invited)
APHRS 2010, 10.27-30, Jeju, Korea
Makiyama T, Watanabe S, Yamamura K, Arima M, Hattori T, Ohno S, Sasaki K, Nishio Y, Itoh H, Akao M, Horie M, Kimura T: Both Gain- and Loss-of-Function Mutations in the Cardiac Na+ Channel Gene, SCN5A, are Associated with Sudden Infant Death Syndrome (SIDS) (oral)
International Society of Nephrology, Nexus Symposium, 7.2, Geneva, Switzerland
1) 柳田素子：The role of BMP and TGF in kidney fibrosis
2) 浅田礼光：Elucidating the heterogeneity of fibroblasts in the kidney
3) 高瀬昌幸：The role of erythropoietin receptors in kidney disease progression
The 43rd Annual Meeting of American society of nephrology, 11.16-21, Denver, USA
1) 遠藤知美：Exploring the origin of the cells responsible for regeneration and fibrosis.
2) 富田真弓：BMP7 maintains nephron progenitor population and determines nephron number
International Society of Nephrology, Nexus Symposium, Kyoto, Japan
遠藤知美：Exploring the origin of the cells regenerating the kidneys
XXth World Congress of the International Society for Heart Research 2010 Kyoto, 5.4, Kyoto, Japan
1) Sunagawa Y, Morimoto T, Wada H, Takaya T, Kawamura T, Yanagi S, Marui A, Ikeda T, Sakata R, Shimatsu A, Kimura T, Fujita M, Hasegawa K: Curcumin exerts synergistic effects with ACE inhibitor during systolic function restoration after myocardial infarction in rats.
2) Suzuki H, Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Uemura K, Shimatsu A, Kimura T, Fujita M, Hasegawa K: Curcumin, a p300 HAT inhibitor, prevents the development of hypertension-induced left ventricular hypertrophy in rats.
3) Yabuki S, Sunagawa Y, Murakami A, Kawaguchi S, Murai N, Wada H, Takahashi K, Fukuda H, Uemura K, Shimatsu A, Kimura T, Fujita M, Hasegawa K, Morimoto T: Nobiletin, a citrus flavonoid, prevents the worsening of heart failure in rats with myocardial infarction.
4) Wada H, Takaya T, Morimoto T, Sunagawa Y, Fujita M, Kimura T, Fujita Y, Sato Y, Shimatsu A, Hasegawa K: Elevated serum levels of soluble lectin-like oxidized low-density lipoprotein receptor-1 in chronic heart failure patients with left ventricular hypertrophy.
5) Kawaguchi S, Sunagawa Y, MurakamiA, Yabuki S, Murai N, Wada H, Takahashi K, Fukuda H, Uemura K, Shimatsu A, Kimura T, Fujita M, Hasegawa K, Morimoto T: A citrus flavonoid, auraptene, prevents the deterioration of systolic function after myocardial infarction in rats.
The 6th China-Japan Cardiovascular Forum 2010, 10.15-16, Beijing, China
1) Sunagawa Y, Yabuki S, Wada H, Murakami A, Murai H, Fukuda H, Katanasaka Y, Kimura T, Shimatsu A, Fujita M, Hasegawa K, Morimoto T: A citrus flavonoid, nobiletin, represses hypertrophic response in cardiac myocytes.
2) Sunagawa Y, Kawaguchi S, Wada H, Murakami A, Murai H, Fukuda H, Katanasaka Y, Kimura T, Shimatsu A, Fujita M, Hasegawa K, Morimoto T: Auraptene, a citrus flavonoid, represses the cardiac hypertrophy in cultured cardiomyocytes.
3) Terada T, Sunagawa Y, Ishibashi Y, Kawamura T, Takaya T, Wada H, Katanasaka Y, Komeda M, Kita T, Shimatsu A, Fujita M, Hasegawa K, Morimoto T: Curcumin suppressed cardiac hypertrophy by inhibiting not only HAT activity but also scaffold function of p300 in cultured cardiomyocytes.
BIT’s 2nd Annual International Congress of Cardiology-2010, 12.7-9, Shanghai,China
1) Takase B, Nagata M, Fujita M: Acute effect of whole-body periodic acceleration on brachial flow-mediated vasodilation assessed by a novel semi-automatic vessel chasing system of UNEXEF18G.
2) Fukuda S, Shimada K, Fujita M, Yoshiyama M, Yoshikawa J: Acute effects of whole-body periodic acceleration on coronary microcirculation and insulin resistance in type 2 diabetic patients.
3) Miyamoto S, Inoko M, Haruna T, Oba M, Saji Y, Nakane E, Abe T, Sasaki K, Itoh H, Fukuda T, Nakashima J, Tanaka N, Ueyama K, Nohara R, Fujita M: Whole-body periodic acceleration with a horizontal motion platform ameliorates exercise tolerance through peripheral effects in chronic heart failure patients and old myocardial infarction.
4) Takahashi Y, Fukuda S, Shimada K, Fujita M: Whole-body periodic acceleration mobilizes CD34+/KDR+ cells in type 2 diabetic patients.
